Similar articles for PMID: 16457695

Year	Number of Results
1951	1
1993	1
1999	1
2000	1
2001	5
2002	3
2003	2
2004	3
2005	8
2006	2
2007	6
2008	4
2009	3
2012	1
2013	1
2024	0

1

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.

Esserman LJ, Ozanne EM, Dowsett M, Slingerland JM. Esserman LJ, et al. Breast Cancer Res. 2005;7(6):R1153-8. doi: 10.1186/bcr1342. Epub 2005 Nov 21. Breast Cancer Res. 2005. PMID: 16457695 Free PMC article.

2

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.

Peshkin BN, Isaacs C, Finch C, Kent S, Schwartz MD. Peshkin BN, et al. J Clin Oncol. 2003 Dec 1;21(23):4322-8. doi: 10.1200/JCO.2003.02.107. J Clin Oncol. 2003. PMID: 14645421

3

The nature of tamoxifen action in the control of female breast cancer.

Kodama M, Kodama T. Kodama M, et al. In Vivo. 2001 Jul-Aug;15(4):319-25. In Vivo. 2001. PMID: 11695224 Review.

4

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B; National Surgical Adjuvant Breast and Bowel Project. King MC, et al. JAMA. 2001 Nov 14;286(18):2251-6. doi: 10.1001/jama.286.18.2251. JAMA. 2001. PMID: 11710890 Clinical Trial.

5

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM. Arpino G, et al. J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61. doi: 10.1093/jnci/dji249. J Natl Cancer Inst. 2005. PMID: 16145046

6

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.

Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI. Grann VR, et al. Cancer J Sci Am. 2000 Jan-Feb;6(1):13-20. Cancer J Sci Am. 2000. PMID: 10696733

7

BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial.

Kote-Jarai Z, Powles TJ, Mitchell G, Tidy A, Ashley S, Easton D, Assersohn L, Sodha N, Salter J, Gusterson B, Dowsett M, Eeles R. Kote-Jarai Z, et al. Cancer Lett. 2007 Mar 18;247(2):259-65. doi: 10.1016/j.canlet.2006.05.003. Epub 2006 Jun 14. Cancer Lett. 2007. PMID: 16777318 Clinical Trial.

8

Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.

Robertson JF. Robertson JF. Cancer Treat Rev. 2004 Dec;30(8):695-706. doi: 10.1016/j.ctrv.2004.04.003. Cancer Treat Rev. 2004. PMID: 15541579 Review.

9

A comparison of bilateral breast cancers in BRCA carriers.

Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D, Lynch HT, McLennan J, Foulkes WD, Wagner T, Tung N, Ghadirian P, Olopade O, Isaacs C, Kim-Sing C, Møller P, Neuhausen SL, Metcalfe K, Sun P, Narod SA. Weitzel JN, et al. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1534-8. doi: 10.1158/1055-9965.EPI-05-0070. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15941968

10

Cross-issue synthesis: potential application to breast cancer, tamoxifen and genetic susceptibility.

Nixon RM, Duffy SW. Nixon RM, et al. J Cancer Epidemiol Prev. 2002;7(4):205-12. J Cancer Epidemiol Prev. 2002. PMID: 12846491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

40 results

Results by year